Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.
Aastrom Biosciences, Inc. Reports First Quarter Fiscal Year 2006 Financial Results Ann Arbor, Michigan, November 9 , 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today reported financial results for the first quarter of fiscal year 2006 ended September 30, 2005. The Company also reported
Aastrom Biosciences CEO to Present at Noble Financial Group Small Cap Conference Ann Arbor, Michigan, November 7, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today R. Douglas Armstrong, Ph.D., Chairman and Chief Executive Officer, will present at the Noble Financial Group Small Cap
Webcast Alert: Aastrom Biosciences Announces Its First Quarter Investor Conference Call Ann Arbor, MI, November 4, 2005 -- Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences First Quarter Fiscal Year End 2006 Investor Conference Call When: Wednesday,
Aastrom Biosciences CEO to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference Ann Arbor, Michigan, November 3, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today R. Douglas Armstrong, Ph.D., Chairman and Chief Executive Officer, will present at the Rodman & Renshaw
Webcast Alert: Aastrom Biosciences Announces Webcast of Its Annual Meeting of Shareholders Ann Arbor, MI, November 1, 2005 -- Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences Fiscal Year End 2005 Annual Meeting of Shareholders When: Wednesday, November
Aastrom Receives Phase II NIH Grant to Support Further Development of Its Proprietary Stem Cell Manufacturing Systems Ann Arbor, Michigan, October 18, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that it has received a Small Business Innovation Research Phase II grant from the
Alan L. Rubino Elected to Aastrom Biosciences' Board of Directors Ann Arbor, Michigan, September 30, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that Alan L. Rubino, a Principal with Watchung Partners, has been elected to the Company's Board of Directors.
